Anh Hoang

2.8k total citations
47 papers, 1.5k citations indexed

About

Anh Hoang is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Anh Hoang has authored 47 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 24 papers in Cancer Research and 19 papers in Molecular Biology. Recurrent topics in Anh Hoang's work include Prostate Cancer Treatment and Research (25 papers), Cancer, Hypoxia, and Metabolism (12 papers) and Cancer, Lipids, and Metabolism (12 papers). Anh Hoang is often cited by papers focused on Prostate Cancer Treatment and Research (25 papers), Cancer, Hypoxia, and Metabolism (12 papers) and Cancer, Lipids, and Metabolism (12 papers). Anh Hoang collaborates with scholars based in United States, Greece and Spain. Anh Hoang's co-authors include Eleni Efstathiou, Christopher J. Logothetis, Patricia Troncoso, Sijin Wen, Μαρία Κάρλου, Mark Titus, Vassiliki Tzelepi, Ana M. Aparicio, Eric Jonasch and Xian-De Liu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Anh Hoang

44 papers receiving 1.5k citations

Peers

Anh Hoang
Xiaotun Zhang United States
Haruhiro Yukiue Japan
Adam G. Sowalsky United States
Debyani Chakravarty United States
Lisha G. Brown United States
Géralyn C. Trudel United States
Ilenia Migliaccio Italy
J. W. Clark United States
Joanna Cyrta France
Jean‐François Martini United States
Xiaotun Zhang United States
Anh Hoang
Citations per year, relative to Anh Hoang Anh Hoang (= 1×) peers Xiaotun Zhang

Countries citing papers authored by Anh Hoang

Since Specialization
Citations

This map shows the geographic impact of Anh Hoang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anh Hoang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anh Hoang more than expected).

Fields of papers citing papers by Anh Hoang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anh Hoang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anh Hoang. The network helps show where Anh Hoang may publish in the future.

Co-authorship network of co-authors of Anh Hoang

This figure shows the co-authorship network connecting the top 25 collaborators of Anh Hoang. A scholar is included among the top collaborators of Anh Hoang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anh Hoang. Anh Hoang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Hyeonhui, et al.. (2025). Protocol for differentiating murine 3T3-L1 and SVF-derived preadipocytes and isolating crude mitochondrial fractions. STAR Protocols. 6(3). 104045–104045. 1 indexed citations
2.
Liu, Xian-De, Yanting Zhang, Daniel J. McGrail, et al.. (2023). SETD2 Loss and ATR Inhibition Synergize to Promote cGAS Signaling and Immunotherapy Response in Renal Cell Carcinoma. Clinical Cancer Research. 29(19). 4002–4015. 8 indexed citations
3.
Gentile, Emanuela, Andrew W. Hahn, Jian H. Song, et al.. (2023). Monitoring Glucocorticoid Receptor in Plasma-derived Extracellular Vesicles as a Marker of Resistance to Androgen Receptor Signaling Inhibition in Prostate Cancer. Cancer Research Communications. 3(12). 2531–2543.
4.
Hahn, Andrew W., Miao Zhang, Anh Hoang, et al.. (2022). Characterization of prostate cancer adrenal metastases: dependence upon androgen receptor signaling and steroid hormones. Prostate Cancer and Prostatic Diseases. 26(4). 751–758. 3 indexed citations
5.
Labanca, Estefanía, Jun Yang, Peter D.A. Shepherd, et al.. (2021). Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuel. Oncogene. 40(44). 6284–6298. 17 indexed citations
6.
Tsikkinis, Alexandros, Anh Hoang, Ana M. Aparicio, et al.. (2020). A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer. Clinical Genitourinary Cancer. 19(1). 22–31.e5. 13 indexed citations
7.
Tsikkinis, Alexandros, Anh Hoang, Ana M. Aparicio, et al.. (2020). A candidate androgen signalling signature predictive of response to abiraterone acetate in men with metastatic castration-resistant prostate cancer. European Journal of Cancer. 127. 67–75. 5 indexed citations
8.
Zhang, Xin, Gang Wang, Anh Hoang, et al.. (2019). REDUCED BRONCHODILATOR REVERSIBILITY CORRELATES WITH SEVERE ASTHMA AND MORE EXACERBATIONS: A PROSPECTIVE 12‐MONTH COHORT STUDY IN A REAL‐WORLD SETTING. Respirology. 24(S2). 274–276. 1 indexed citations
9.
Aung, Phyu P., Edwin R. Parra, Souptik Barua, et al.. (2019). B7-H3 Expression in Merkel Cell Carcinoma–Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular Density. Clinical Cancer Research. 25(11). 3455–3467. 29 indexed citations
10.
11.
Tzelepi, Vassiliki, Eleni Efstathiou, Patricia Troncoso, et al.. (2019). Epigenetics and prostate cancer: defining the timing of DNA methyltransferase deregulation during prostate cancer progression. Pathology. 52(2). 218–227. 31 indexed citations
12.
Varkaris, Andreas, Paul G. Corn, Nila U. Parikh, et al.. (2015). Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer. Clinical Cancer Research. 22(1). 107–121. 37 indexed citations
13.
Efstathiou, Eleni, Mark Titus, Sijin Wen, et al.. (2014). Molecular Characterization of Enzalutamide-treated Bone Metastatic Castration-resistant Prostate Cancer. European Urology. 67(1). 53–60. 185 indexed citations
14.
Satcher, Robert L., Tianhong Pan, Chien-Jui Cheng, et al.. (2014). Cadherin-11 in Renal Cell Carcinoma Bone Metastasis. PLoS ONE. 9(2). e89880–e89880. 32 indexed citations
15.
Efstathiou, Eleni, Mark Titus, Sijin Wen, et al.. (2014). Enzalutamide (ENZA) in combination with abiraterone acetate (AA) in bone metastatic castration resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 32(15_suppl). 5000–5000. 29 indexed citations
16.
Κάρλου, Μαρία, Jing‐Fang Lu, Guanglin Wu, et al.. (2012). Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC‐0449 in the bone forming prostate cancer xenograft MDA PCa 118b. The Prostate. 72(15). 1638–1647. 26 indexed citations
17.
Efstathiou, Eleni, Μαρία Κάρλου, Sijin Wen, et al.. (2012). Integrated Hedgehog signaling is induced following castration in human and murine prostate cancers. The Prostate. 73(2). 153–161. 17 indexed citations
18.
Tzelepi, Vassiliki, Jiexin Zhang, Guanglin Wu, et al.. (2011). Modeling a Lethal Prostate Cancer Variant with Small-Cell Carcinoma Features. Clinical Cancer Research. 18(3). 666–677. 105 indexed citations
19.
Tzelepi, Vassiliki, Μαρία Κάρλου, Sijin Wen, et al.. (2011). Expression of hedgehog pathway components in prostate carcinoma microenvironment: shifting the balance towards autocrine signalling. Histopathology. 58(7). 1037–1047. 32 indexed citations
20.
Tsao, Chun C., Bin Tean Teh, Eric Jonasch, et al.. (2008). Inhibition of Mxi1 suppresses HIF-2α-dependent renal cancer tumorigenesis. Cancer Biology & Therapy. 7(10). 1619–1627. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaotun Zhang Breakdown of academic impact, for papers by Haruhiro Yukiue Breakdown of academic impact, for papers by Adam G. Sowalsky Breakdown of academic impact, for papers by Debyani Chakravarty Breakdown of academic impact, for papers by Lisha G. Brown Breakdown of academic impact, for papers by Géralyn C. Trudel Breakdown of academic impact, for papers by Ilenia Migliaccio Breakdown of academic impact, for papers by J. W. Clark Breakdown of academic impact, for papers by Joanna Cyrta Breakdown of academic impact, for papers by Jean‐François Martini
Rankless by CCL
2026